Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Growth Factors. 2011 Sep 13;29(6):278–289. doi: 10.3109/08977194.2011.616200

Figure 2.

Figure 2

Total and phosphorylated IRS-1 (Y632), FAK (Y925) western blots from CRL-2329, CRL-2335, Hs578T and MCF-7 breast cancer cells. (A) shows IRS-1 and FAK western blot in AA and CA breast cancer cells for comparison purposes. (B–E) shows total and phosphorylated IRS-1 and FAK 20 minutes without any treatment (control) or after treatment with precursor or mature IGF-II (pro- or mIGF-II, 100 ng/ml) or insulin (100 nM). β-actin was used as loading control.